Position in DHR
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$336,768
+$51,422 QoQ
Shares Held
1,768
+17.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#1,546
of 2,098 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026YANKCOM Partnership holds $2,599,880 across 6 Diagnostics & Research names. DHR ranks #3 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
6,383 | $1,352,875 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,342 | $672,824 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
1,768 | $336,768 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
365 | $192,150 | |
| 5 | LH |
Labcorp Holdings Inc.
|
92 | $25,760 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
86 | $19,503 |
All Filings in DHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $336,768 | 1,768 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $285,346 | 1,505 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $301,258 | 1,316 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $257,538 | 1,299 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $227,367 | 1,151 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $217,915 | 1,063 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $237,354 | 1,034 | Shares | Defined | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||